These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17390380)

  • 1. Peptides derived from a secretory yeast library restore factor VIII activity in the presence of an inhibitory antibody.
    Mersich C; Billes W; Pabinger I; Jungbauer A
    Biotechnol Bioeng; 2007 Sep; 98(1):12-21. PubMed ID: 17390380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    Thromb Haemost; 2005 Nov; 94(5):933-41. PubMed ID: 16363233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic parameters of monoclonal antibodies ESH2, ESH4, ESH5, and ESH8 on coagulation factor VIII and their influence on factor VIII activity.
    Egler C; Albert T; Brokemper O; Zabe-Kühn M; Mayer G; Oldenburg J; Schwaab R
    J Mol Recognit; 2009; 22(4):301-6. PubMed ID: 19266540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimerization of peptide mimotopes for blocking of factor VIII neutralizing antibodies.
    Kessel C; Kreuz W; Klich K; Becker-Peters K; Vorpahl F; Dietrich U; Klingebiel T; Königs C
    ChemMedChem; 2009 Aug; 4(8):1364-70. PubMed ID: 19533722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage display technology: a tool to explore the diversity of inhibitors to blood coagulation factor VIII.
    Voorberg J; van den Brink EN
    Semin Thromb Hemost; 2000; 26(2):143-50. PubMed ID: 10919406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight peptides restore the procoagulant activity of factor VIII in the presence of the potent inhibitor antibody ESH8.
    Villard S; Piquer D; Raut S; Léonetti JP; Saint-Remy JM; Granier C
    J Biol Chem; 2002 Jul; 277(30):27232-9. PubMed ID: 12011059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural antibodies to factor VIII.
    Lacroix-Desmazes S; Moreau A; Pashov A; Sooryanarayana ; Stahl D; Saint-Remy JM; Kaveri SV; Kazatchkine MD
    Semin Thromb Hemost; 2000; 26(2):157-65. PubMed ID: 10919408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous detection and epitope mapping of anti-factor VIII antibodies.
    Lavigne-Lissalde G; Tarrade C; Lapalud P; Chtourou S; Schved JF; Granier C; Villard-Saussine S
    Thromb Haemost; 2008 Jun; 99(6):1090-6. PubMed ID: 18521513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.
    Brown JE; Carton CL; Hougie C
    J Lab Clin Med; 1981 Jan; 97(1):65-71. PubMed ID: 6778942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-factor VIII antibodies: a 2005 update.
    Lavigne-Lissalde G; Schved JF; Granier C; Villard S
    Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide mimics of a conserved H5N1 avian influenza virus neutralization site.
    Luo W; Chen Y; Wang M; Chen Y; Zheng Z; Song H; Chen H; Guan Y; Ng MH; Zhang J; Xia N
    Biochem J; 2009 Apr; 419(1):133-9. PubMed ID: 18973474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New high-technology products for the treatment of haemophilia.
    Pipe SW; Saint-Remy JM; Walsh CE
    Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH; Marbet GA; Duckert F
    Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel peptide isolated from phage display peptides library recognized by an antibody against connective tissue growth factor (CTGF).
    Liu N; Wu G; Li H; Li L; Xing H; Zhang C; Lu H
    Int Immunopharmacol; 2009 Mar; 9(3):291-7. PubMed ID: 19103307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The B-cell epitope of the monoclonal anti-factor VIII antibody ESH8 characterized by peptide array analysis.
    Albert T; Egler C; Jakuschev S; Schuldenzucker U; Schmitt A; Brokemper O; Zabe-Kühn M; Hoffmann D; Oldenburg J; Schwaab R
    Thromb Haemost; 2008 Mar; 99(3):634-7. PubMed ID: 18327416
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of oriented or random PEGylation on bioactivity of a factor VIII inhibitor blocking peptide.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    Biotechnol Bioeng; 2006 Mar; 93(4):647-55. PubMed ID: 16395719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
    Kessel C; Königs C; Linde R; Escuriola-Ettinghausen C; Stoll H; Klingebiel T; Dietrich U; Kreuz W
    Mol Immunol; 2008 Nov; 46(1):8-15. PubMed ID: 18715645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.